Screener
Ingevity NGVT Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Ingevity in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Ingevity’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:26 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001653477-26-000035
| In millions, except share and par value data | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Cash and cash equivalents | $95.4 | $78.1 |
| Accounts receivable, net of allowance of $1.4 - 2026 and $1.5 - 2025 | 151.2 | 127.2 |
| Inventories, net | 203.6 | 186.0 |
| Restricted investment, net of allowance of $0.2 - 2026 | 85.1 | — |
| Prepaid and other current assets | 46.5 | 47.0 |
| Current assets of discontinued operations | — | 15.9 |
| Current assets | 581.8 | 454.2 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ingevity's cash & equivalents?
- Ingevity (NGVT) reported cash & equivalents of $95.4M in Q1 2026.
- How has Ingevity's cash & equivalents changed year-over-year?
- Ingevity's cash & equivalents increased by 5.0% year-over-year, from $90.9M to $95.4M.
- What is the long-term trend for Ingevity's cash & equivalents?
- Over 5 years (2020 to 2025), Ingevity's cash & equivalents has grown at a -21.3% compound annual growth rate (CAGR), from $258.4M to $78.1M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Ingevity's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude